Aerocrine AB   Report issue

For profit Phase 4
Founded: Solna Sweden (1997)
Status: Acquired by Circassia Limited (2015)

Organization Overview

First Clinical Trial
2006
NCT00421018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cough (Phase 4)

Signs and Symptoms, Respiratory (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3